Indication
pemphigoid
2 clinical trials
5 products
Product
Mometasone furoateClinical trial
Double-Blind, Randomized, Placebo-Controlled Trial of AKST4290 for Adjunctive Treatment of Mild to Moderate Bullous PemphigoidStatus: Terminated, Estimated PCD: 2021-03-29
Product
PlaceboProduct
AKST4290Clinical trial
Phase IIa Multicenter Clinical Trial to Determine the Feasibility and Safety of the Use of Adipose-derived Mesenchymal Stem Cells (ASC) in the Treatment of Patients With Cicatricial Conjunctivitis Associated With Lyell's Syndrome, Stevens-Johnson Syndrome and Pemphigoid of the Mucous Membranes With Ocular Involvement.Status: Active (not recruiting), Estimated PCD: 2024-02-01
Product
Single DoseProduct
Double Dose